Note: This is a project under development. The articles on this wiki are just being initiated and broadly incomplete. You can Help creating new pages.
Difference between revisions of "Diabecon"
| (One intermediate revision by the same user not shown) | |||
| Line 6: | Line 6: | ||
[[Category:Proprietary Ayurvedic Medicine]] | [[Category:Proprietary Ayurvedic Medicine]] | ||
| + | [[Category:Himalaya Drugs Company]] | ||
Latest revision as of 12:18, 2 April 2018
The natural ingredients in Diabecon increase insulin secretion in the body. By reducing the glycated hemoglobin level (form of hemoglobin used to measure glucose content in the blood) level, normalizing microalbuminuria (a condition which is an important prognostic marker for kidney disease in diabetes mellitus) and modulating the lipid profile, Diabecon minimizes long-term diabetic complications. The drug also increases hepatic and muscle glycogen content, which enhances the peripheral utilization of glucose.
Anti-hyperglycemic: Diabecon reduces high glucose content in the blood. Effective hyperglycemic control is important in preventing micro- and macrovascular complications (large and small blood vessels) arising from diabetes.
